Similar articles

• Age as a predictor of treatment response in endogenous depression.

  Brown RP, Sweeney J, Frances A, Kocsis JH, Loutsch E. Brown RP, et al. J Clin Psychopharmacol. 1983 Jun;3(3):176-8. J Clin Psychopharmacol. 1983. PMID: 6875025 No abstract available.
• [Clinical trial with oxytryptan in depressions].

  Ruiz Ruiz M, Herrera D, Buil R, Lafuente M, Samada P, Zeledón F, Lillo JL. Ruiz Ruiz M, et al. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1981 Jul-Aug;9(4):325-30. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1981. PMID: 7032243 Clinical Trial. Spanish. No abstract available.
• Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patients.

  Jann MW, Bitar AH, Rao A. Jann MW, et al. Am J Psychiatry. 1982 May;139(5):683-4. doi: 10.1176/ajp.139.5.683. Am J Psychiatry. 1982. PMID: 7072862 No abstract available.
• [EEG patterns in the states of wakefulness and sleep during treatment with tricyclic antidepressive agents (imipramine, amitriptyline)].

  Ekiert H, Gogol Z. Ekiert H, et al. Psychiatr Pol. 1983;17(1):57-64. Psychiatr Pol. 1983. PMID: 6353458 Review. Polish. No abstract available.
• The role of antidepressants in the treatment of affective disorders.

  Blaine JD, Prien RF, Levine J. Blaine JD, et al. Am J Psychother. 1983 Oct;37(4):502-20. doi: 10.1176/appi.psychotherapy.1983.37.4.502. Am J Psychother. 1983. PMID: 6318580 Review.